Skip to Content

H 13 9 (Abacavir sulfate 300 mg (base))

Pill imprint H 13 9 has been identified as Abacavir sulfate 300 mg (base).

Abacavir is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Abacavir 300 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Abacavir sulfate 300 mg (base) H 13 9
Abacavir sulfate 300 mg (base) H 13 9
Discount Card Promo
Abacavir sulfate
Imprint:
H 13 9
Strength:
300 mg (base)
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Camber Pharmaceuticals, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide